Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hemangiosarcoma × ribociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 15 Glioma 3 Ovarian Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 2 Melanoma 2 Diffuse Intrinsic Pontine Glioma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Osteitis Deformans 1 Non functioning pancreatic endocrine tumor 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Mesothelioma 1 Medulloblastoma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Glioblastoma 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Estrogen Receptor and/or Progesterone Receptor Positive 1 Cystadenocarcinoma, Serous 1 Breast Neoplasms, Male 1

Interventions

pazopanib 5 Doxorubicin 3 carotuximab 2 Sorafenib 2 Radiotherapy, Conformal 2 Gemcitabine 2 tremelimumab 1 trebananib 1 temsirolimus 1 romidepsin 1 indolepropanol phosphate 1 eribulin 1 durvalumab 1 cixutumumab 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Sirolimus 1 Razoxane 1 Paclitaxel 1 Observation 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 HhAntag691 1 Fluorodeoxyglucose F18 1 Docetaxel 1 Dexrazoxane 1 Cyproheptadine 1 Bevacizumab 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡